TP53 and acute kidney injury: Interestingly, a Phase 3 study with siRNA targeting p53 (QPI-1002) is undergoing to evaluate the prevention for AKI following cardiac surgery (https://clinicaltrials.gov/ct2/show/NCT03510897).